Stay updated on HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial

Sign up to get notified when there's something new on the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.2 to v3.5.3, indicating a new build of the page. The listed change does not alter study content, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-04-30T17:07:27.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T11:13:27.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No visible changes to study details or page behavior.
    Difference
    0.1%
    Check dated 2026-03-18T19:18:10.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Version updated from v3.4.2 to v3.4.3. No user-facing content or study details appear to be changed.
    Difference
    0.1%
    Check dated 2026-03-11T17:02:29.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now shown; the prior funding-related notice and the v3.4.1 revision have been removed, with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:41:04.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Introduced a government funding update notice and updated the site revision to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T05:20:07.000Z thumbnail image

Stay in the know with updates to HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page.